2003649 D.C. Board of Elections, Notice of Public Hearing, "District of Columbia Limited Micro-Technology Ban"
-
BOARD OF ELECTIONS
NOTICE OF PUBLIC HEARING
RECEIPT AND INTENT TO REVIEW INITIATIVE MEASURE
The Board of Elections shall consider in a public hearing whether the proposed measure “District of Columbia Limited Micro-Technology Ban” is a proper subject matter for initiative, at the Board’s Monthly Meeting on Tuesday, March 13, 2012 at 10:30am., One Judiciary Square, 441 4th Street, N.W., Suite 280, Washington DC.
The Board requests that written memoranda be submitted for the record no later than 4:00 p.m., Thursday, March 8, 2012 to the Board of Elections, General Counsel’s Office, One Judiciary Square, 441 4th Street, N.W., Suite 270, Washington, D.C. 20001.
Each individual or representative of an organization who wishes to present testimony at the public hearing is requested to furnish his or her name, address, telephone number and name of the organization represented (if any) by calling the General Counsel’s office at 727-2194 no later than Friday, March 9, 2012 at 4:00p.m.
The Short Title, Summary Statement and Legislative Text of the proposed initiative read as follows:
SHORT TITLE
District of Columbia Limited Micro-Technology Ban
SUMMARY STATEMENT
It shall be illegal in the District of Columbia for any organization, Police department personnel, fire department personnel, paramedics (except in emergency cases where in the performance of paramedic duties such similar devices are required to save lives,), Federal agents, residents of the District of Columbia, and visitors to the District of Columbia to operate micro-needle technology outside of a health care facility or interrogation unit. It shall be a criminal offense for anyone to possess micro-needle delivery systems with the capacity to inject micro-needles, or other micro objects into persons residing in the District of Columbia.
LEGISLATIVE TEXT
Because of biological, chemical, and pharmaceutical threats posed by microneedle technology and the potential for abuse by individuals and the lack of accountability by administrators of microneedle technology in the public sector this proposition bans in the District of Columbia any and all portable hand held mechanisms, or, and delivery systems which shoots or projects splinters, microneedles, spikes or similar projectiles. It shall be illegal in The District of Columbia for any organization, Police department personnel, fire department personnel, paramedics (except in emergency cases where in the performance of paramedic duties such similar devices are required to save lives,), federal agents, residents of the District of Columbia, and visitors to the District of Columbia to operate such devices. It shall be a criminal offence for anyone to poses a delivery system or mechanism which has the capacity to shoot or project micro-nreedles, splinters or spikes or any other micro objects into persons or person or bodies of residents who reside in The District of Columbia or to shoot any micro-needles projectile into any person or persons visiting the District of Columbia. Any violation of this ban is just cause for arrest and prosecution by the superior court in the District of Columbia.
This proposition meets criteria set forth in SEC. 125. ACCELERATED COUNTERMEASURE RESEARCH AND DEVELOPMENT, Section 319F(h) of the Public Health Service Act, as redesignated by section 104(a)(2) of this Act, <<NOTE: 42 USC 247d-6.>> that is amended to read as follows:
(h) Accelerared Research and Development on Priority Pathogens and Countermeasures.—
“( C ) the development of priority countermeasures; and
[[ Page 116 STAT.615]]
(4) Priority countermeasures.--For purposes of his section, the term ‘priority countermeasure’ means a drug, biological product, device, vaccine, vaccine adjuvant, antiviral, or diagnosis test that the Secretary determine to be--
A) a priority to treat, identify, or prevent infection by a biological agent or toxin listed pursuant to section 351A(a)(1), or harm from any other agent that may cause a public health emergency; or (B) a priority to diagnose conditions that may result in adverse health consequences or death and may be caused by the administering of a drug, biological product, device, vaccine adjuvant, antiviral, or diagnostic test that is s priority under subparagraph (A).”.
